Hydroxyzine Pamoate
- Product NDC
- 70518-3311
- 11-digit product format
- 705183311
- Labeler code
- 70518
- Product ID
- 70518-3311_ea4dc439-f085-3f0b-e053-2995a90ae4f6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydroxyzine Pamoate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA088487
- Marketing category
- ANDA
- Marketing start
- 2021-12-27
- Marketing end
- 0000-00-00
- Substance
- HYDROXYZINE PAMOATE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Antihistamine [EPC], Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3311-0 | 70518331100 | 100 POUCH in 1 BOX (70518-3311-0) > 1 CAPSULE in 1 POUCH (70518-3311-1) | 100 pouch | 2021-12-27 | 0000-00-00 | No | No | Current |
| 70518-3311-2 | 70518331102 | 30 CAPSULE in 1 BLISTER PACK (70518-3311-2) | 30 capsule | 2022-03-21 | 0000-00-00 | No | No | Current |
| 70518-3311-3 | 70518331103 | 30 CAPSULE in 1 BLISTER PACK (70518-3311-3) | 30 capsule | 2022-08-25 | 0000-00-00 | No | No | Current |